Works matching IS 02780232 AND DT 2022 AND VI 40

Results: 131

Lack of efficacy of convalescent plasma in COVID‐19 patients with concomitant hematological malignancies: An Italian retrospective study.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 857, doi. 10.1002/hon.3060
By:
- Lanza, Francesco;
- Monaco, Federica;
- Ciceri, Fabio;
- Cairoli, Roberto;
- Sacchi, Maria Vittoria;
- Guidetti, Anna;
- Marchetti, Monia;
- Massaia, Massimo;
- Arcaini, Luca;
- Krampera, Mauro;
- Mohamed, Sara;
- Gherlinzoni, Filippo;
- Mecucci, Cristina;
- Gentile, Massimo;
- Romano, Ilaria;
- Venditti, Adriano;
- Ruggeri, Marco;
- Ferrero, Dario;
- Coviello, Elisa;
- Fabbri, Elisabetta
Publication type:
Article
Clinical significance of MYD88 non‐L265P mutations in diffuse large B‐cell lymphoma.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 885, doi. 10.1002/hon.3073
By:
- Xie, Jialing;
- Shen, Xia;
- Shi, Qin;
- Yi, Hongmei;
- Ouyang, Binshen;
- Zhang, Zhihan;
- Gu, Yijin;
- Dong, Lei
Publication type:
Article
The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 962, doi. 10.1002/hon.3063
By:
- De Luca, Giuseppa;
- Cerruti, Giannamaria;
- Lastraioli, Sonia;
- Conte, Romana;
- Ibatici, Adalberto;
- Di Felice, Nikki;
- Morabito, Fortunato;
- Monti, Paola;
- Fronza, Gilberto;
- Matis, Serena;
- Colombo, Monica;
- Fabris, Sonia;
- Ciarrocchi, Alessia;
- Neri, Antonino;
- Menichini, Paola;
- Ferrarini, Manlio;
- Nozza, Paolo;
- Fais, Franco;
- Cutrona, Giovanna;
- Dono, Mariella
Publication type:
Article
Dual epigenetic agents plus rituximab–gemcitabine–oxaliplatin as salvage treatment in relapsed/refractory diffuse large B‐cell lymphoma patients failure of salvage chemotherapy.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 914, doi. 10.1002/hon.3052
By:
- Qu, Changju;
- Ping, Nana;
- Kong, Danqing;
- Liu, Aining;
- Liu, Hailing;
- Xu, Ting;
- Xia, Fan;
- Wu, Depei;
- Jin, Zhengming
Publication type:
Article
Characteristics and clinical outcomes of patients with ALK‐positive anaplastic large cell lymphoma: Report from the prospective international T‐cell lymphoma project.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 953, doi. 10.1002/hon.3074
By:
- Chiattone, Carlos;
- Civallero, Monica;
- Fischer, Thais;
- Miranda, Eliana;
- Manni, Martina;
- Zing, Natalia P. C.;
- Pileri, Stefano A.;
- Montoto, Silvia;
- Horwitz, Steven M.;
- Cabrera, Maria Elena;
- De Souza, Carmino A.;
- Nagler, Arnon;
- Luminari, Stefano;
- Ferreri, Andrés J. M.;
- Carson, Kenneth R.;
- Re, Alessandro;
- Rigacci, Luigi;
- Nassi, Luca;
- Stepanishyna, Yana;
- Federico, Massimo
Publication type:
Article
Prognostic impact of complex karyotype on post‐transplant outcomes of myelofibrosis.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 1076, doi. 10.1002/hon.3058
By:
- Okada, Yosuke;
- Takenaka, Katsuto;
- Murata, Makoto;
- Shimazu, Yutaka;
- Tachibana, Takayoshi;
- Ozawa, Yukiyasu;
- Uchida, Naoyuki;
- Wakayama, Toshio;
- Doki, Noriko;
- Sugio, Yasuhiro;
- Tanaka, Masatsugu;
- Masuko, Masayoshi;
- Kobayashi, Hikaru;
- Ino, Kazuko;
- Ishikawa, Jun;
- Nakamae, Hirohisa;
- Matsuoka, Ken‐ichi;
- Kanda, Yoshinobu;
- Fukuda, Takahiro;
- Atsuta, Yoshiko
Publication type:
Article
Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies: A report from the ITA‐HEMA‐COV.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 846, doi. 10.1002/hon.3048
By:
- Zappasodi, Patrizia;
- Cattaneo, Chiara;
- Valeria Ferretti, Virginia;
- Mina, Roberto;
- José María Ferreri, Andrés;
- Merli, Francesco;
- Oberti, Margherita;
- Krampera, Mauro;
- Romano, Alessandra;
- Zerbi, Caterina;
- Ferrari, Jacqueline;
- Cavo, Michele;
- Salvini, Marco;
- Bertù, Lorenza;
- Stefano Fracchiolla, Nicola;
- Marchesi, Francesco;
- Massaia, Massimo;
- Marasco, Vincenzo;
- Cairoli, Roberto;
- Maria Scattolin, Anna
Publication type:
Article
CCR7 alterations associated with inferior outcome of adult T‐cell leukemia/lymphoma under mogamulizumab treatment.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 876, doi. 10.1002/hon.3072
By:
- Sakamoto, Yuma;
- Ishida, Takashi;
- Masaki, Ayako;
- Murase, Takayuki;
- Ohtsuka, Eiichi;
- Takeshita, Morishige;
- Muto, Reiji;
- Iwasaki, Hiromi;
- Ito, Asahi;
- Kusumoto, Shigeru;
- Nakano, Nobuaki;
- Tokunaga, Masahito;
- Yonekura, Kentaro;
- Tashiro, Yukie;
- Iida, Shinsuke;
- Utsunomiya, Atae;
- Ueda, Ryuzo;
- Inagaki, Hiroshi
Publication type:
Article
Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 1056, doi. 10.1002/hon.3068
By:
- Lauritsen, Tine Bichel;
- Østgård, Lene Sofie Granfeldt;
- Grønbæk, Kirsten;
- Dalton, Susanne Oksbjerg;
- Nørgaard, Jan Maxwell
Publication type:
Article
A phase 1 study of ruxolitinib, steroids and lenalidomide for relapsed/refractory multiple myeloma patients.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 906, doi. 10.1002/hon.3066
By:
- Berenson, James R.;
- Kim, Clara;
- Bujarski, Sean;
- To, Jennifer;
- Spektor, Tanya M.;
- Martinez, Daisy;
- Turner, Carley;
- Ghermezi, Matthew;
- Eades, Benjamin M.;
- Swift, Regina A.;
- Schwartz, Gary;
- Eshaghian, Shahrooz;
- Moss, Robert A.;
- Lim, Stephen;
- Vescio, Robert
Publication type:
Article
Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera<sup>®</sup>) in combination with CHOP in patients with previously untreated CD20‐positive diffuse large B‐cell lymphoma: A randomized, single‐blind, phase III clinical trial
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 930, doi. 10.1002/hon.3054
By:
- Shi, Yuankai;
- Zhang, Qingyuan;
- Hong, Xiaonan;
- Wang, Zhen;
- Gao, Yuhuan;
- Zou, Liqun;
- Cen, Hong;
- Gui, Lin;
- Li, Yufu;
- Feng, Jifeng;
- Wang, Zhao;
- Zhang, Mingzhi;
- Jin, Chuan;
- Zhang, Weihua;
- Hu, Jianda;
- Zheng, Chengyun;
- Zheng, Zhendong;
- Zhang, Liling;
- Chen, Shaoshui;
- Huang, Yunhong
Publication type:
Article
Therapeutic management and outcome of patients with advanced systemic mastocytosis treated with midostaurin: A comprehensive real‐life study in the French national healthcare database.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 1030, doi. 10.1002/hon.3062
By:
- Rossignol, Julien;
- Nizard, Sandra;
- Blanc, Anne‐Sandrine;
- Filipovics, Anne;
- Lortet‐Tieulent, Joannie;
- Bouktit, Hassiba;
- Poinsot, Gwendoline;
- Schmidt, Aurélie;
- Raguideau, Fanny;
- Hermine, Olivier
Publication type:
Article
Flow cytometric evaluation of measurable residual disease in chronic lymphocytic leukemia: Where do we stand?
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 835, doi. 10.1002/hon.3037
By:
- D'Arena, Giovanni;
- Sgambato, Alessandro;
- Volpe, Silvestro;
- Coppola, Giuseppe;
- Amodeo, Rachele;
- Tirino, Virginia;
- D'Auria, Fiorella;
- Statuto, Teodora;
- Valvano, Luciana;
- Pietrantuono, Giuseppe;
- Deaglio, Silvia;
- Efremov, Dimitar;
- Laurenti, Luca;
- Aiello, Antonella
Publication type:
Article
Outcomes of second allogeneic stem cell transplantation and anti‐relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysis.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 763, doi. 10.1002/hon.2995
By:
- Shumilov, Evgenii;
- Hasenkamp, Justin;
- Maulhardt, Markus;
- Mazzeo, Paolo;
- Schmidt, Nicole;
- Boyadzhiev, Hristo;
- Jung, Wolfram;
- Ganster, Christina;
- Haase, Detlef;
- Koch, Raphael;
- Wulf, Gerald
Publication type:
Article
Ibrutinib combined with low‐dose histone deacetylases inhibitor chidamide synergistically enhances the anti‐tumor effect in B‐cell lymphoma.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 894, doi. 10.1002/hon.3056
By:
- Yu, Hui;
- Mi, Lan;
- Zhang, Weimin;
- Ye, Yingying;
- Li, Miaomiao;
- Hu, Dingyao;
- Cao, Jiaowu;
- Wang, Dedao;
- Wang, Xiaogan;
- Ding, Ning;
- Song, Yuqin;
- Zhu, Jun
Publication type:
Article
Long‐term follow‐up and health‐related quality of life among cancer survivors with stage IEA orbital‐type lymphoma after external photon‐beam radiotherapy: Results from a longitudinal study.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 922, doi. 10.1002/hon.3053
By:
- Hoffmann, Christian;
- Rating, Philipp;
- Bechrakis, Nikolaos;
- Eckstein, Anja;
- Sokolenko, Ekaterina;
- Jabbarli, Leyla;
- Westekemper, Henrike;
- Mohr, Christopher;
- Schmeling, Claus;
- Huettmann, Andreas;
- von Tresckow, Julia;
- Göricke, Sophia;
- Deuschl, Cornelius;
- Johansson, Patricia;
- Poettgen, Christoph;
- Gauler, Thomas;
- Guberina, Nika;
- Moliavi, Sourour;
- Stuschke, Martin;
- Guberina, Maja
Publication type:
Article
NR1H3 (LXRα) is associated with pro‐inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b‐cell lymphoma.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 864, doi. 10.1002/hon.3050
By:
- Vegliante, Maria Carmela;
- Mazzara, Saveria;
- Zaccaria, Gian Maria;
- De Summa, Simona;
- Esposito, Flavia;
- Melle, Federica;
- Motta, Giovanna;
- Sapienza, Maria Rosaria;
- Opinto, Giuseppina;
- Volpe, Giacomo;
- Bucci, Antonella;
- Gargano, Grazia;
- Enjuanes, Anna;
- Tabanelli, Valentina;
- Fiori, Stefano;
- Minoia, Carla;
- Clemente, Felice;
- Negri, Antonio;
- Gulino, Alessandro;
- Morello, Gaia
Publication type:
Article
D<sub>max</sub>: A simple and reliable PET/CT‐derived new biomarker of lymphoma outcome?
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 843, doi. 10.1002/hon.3049
By:
- Ceriani, Luca;
- Zucca, Emanuele
Publication type:
Article
Issue Information.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 819, doi. 10.1002/hon.2893
Publication type:
Article
Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 577, doi. 10.1002/hon.3030
By:
- Kumari, Sarita;
- Ali, M. Shadab;
- Singh, Jay;
- Arora, Mohit;
- Verma, Deepak;
- Pandey, Avanish Kumar;
- Benjamin, Mercilena;
- Bakhshi, Sameer;
- Palanichamy, Jayanth Kumar;
- Sharma, Atul;
- Singh, Inder;
- Tanwar, Pranay;
- Singh, Amar Ranjan;
- Pushpam, Deepam;
- Qamar, Imteyaz;
- Chopra, Anita
Publication type:
Article
Increased risk of nonrelapse mortality post T‐cell‐replete haploidentical stem cell transplantation in patients with recurrence of acute graft‐versus‐host disease.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 743, doi. 10.1002/hon.2999
By:
- Peng, Bo;
- Dou, Liping;
- Yang, Jingjing;
- Wang, Lili;
- Li, Fei;
- Gao, Xiaoning;
- Wang, Shuhong;
- Jin, Xiangshu;
- Wang, Lu;
- Jia, Mingyu;
- Wang, Shenyu;
- Li, Yan;
- Liu, Daihong
Publication type:
Article
Adult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 1041, doi. 10.1002/hon.3046
By:
- Morita‐Fujita, Mari;
- Arai, Yasuyuki;
- Kondo, Tadakazu;
- Harada, Kaito;
- Uchida, Naoyuki;
- Toya, Takashi;
- Ozawa, Yukiyasu;
- Fukuda, Takahiro;
- Ota, Shuichi;
- Onizuka, Makoto;
- Kanda, Yoshinobu;
- Maruyama, Yumiko;
- Takada, Satoru;
- Kawakita, Toshiro;
- Ara, Takahide;
- Ichinohe, Tatsuo;
- Kimura, Takafumi;
- Atsuta, Yoshiko;
- Kako, Shinichi
Publication type:
Article
Mechanisms underlying synergism between circularized tumor necrosis factor‐related apoptosis inducing ligand and bortezomib in bortezomib‐sensitive or ‐resistant myeloma cells.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 999, doi. 10.1002/hon.3045
By:
- Leng, Yun;
- Hu, Xiaoyan;
- Li, Lin;
- Nkwocha, Jewel;
- Satta, Toshihisa;
- Sharma, Kanika;
- Kmeiciak, Maciej;
- Zhou, Huixing;
- Zhang, Zhiyao;
- Zhou, Liang;
- Chen, Wenming;
- Grant, Steven
Publication type:
Article
Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 976, doi. 10.1002/hon.3044
By:
- Younan, Nadia;
- Soussain, Carole;
- Choquet, Sylvain;
- Cassoux, Nathalie;
- Touitou, Valérie;
- Schmitt, Anna;
- Chinot, Olivier;
- Oberic, Lucie;
- Damaj, Gandhi;
- Houot, Roch;
- Ghesquières, Hervé;
- Laribi, Kamel;
- Ahle, Guido;
- Taillandier, Luc;
- Paillassa, Jérôme;
- Gyan, Emmanuel;
- Jardin, Fabrice;
- Delwail, Vincent;
- Marolleau, Jean‐Pierre;
- Tempescul, Adrian
Publication type:
Article
Pirarubicin‐based intensive chemotherapy followed by consolidative high‐dose chemotherapies for peripheral T‐cell lymphomas: A noncomparative phase 2 study.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 1094, doi. 10.1002/hon.3043
By:
- Takahashi, Hiromichi;
- Miura, Katsuhiro;
- Nakagawa, Masaru;
- Nishimaki, Haruna;
- Ito, Shun;
- Nukariya, Hironao;
- Kurihara, Kazuya;
- Endo, Toshihide;
- Koike, Takashi;
- Hamada, Takashi;
- Iizuka, Kazuhide;
- Ohatake, Shimon;
- Iriyama, Noriyoshi;
- Nakayama, Tomohiro;
- Masuda, Shinobu;
- Hatta, Yoshihiro;
- Nakamura, Hideki
Publication type:
Article
Brentuxinmab vedotin, alone or combine with bendamustine in the treatment of natural killer T cell lymphoma.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 941, doi. 10.1002/hon.3042
By:
- Zhang, Ping;
- Shi, Cunzhen;
- Song, Yue;
- Li, Zhaoming;
- Zhang, Mingzhi;
- Jin, Mengyuan
Publication type:
Article
Network meta‐analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 987, doi. 10.1002/hon.3041
By:
- Botta, Cirino;
- Gigliotta, Emilia;
- Paiva, Bruno;
- Anselmo, Rita;
- Santoro, Marco;
- Otero, Paula Rodriguez;
- Carlisi, Melania;
- Conticello, Concetta;
- Romano, Alessandra;
- Solimando, Antonio Giovanni;
- Cerchione, Claudio;
- Vià, Matteo Da;
- Bolli, Niccolò;
- Correale, Pierpaolo;
- Di Raimondo, Francesco;
- Gentile, Massimo;
- San Miguel, Jesus;
- Siragusa, Sergio
Publication type:
Article
BCR/ABL1ΔE7‐8‐9 isoform contributes to tyrosine kinase inhibitor resistance in chronic myeloid leukemia.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 1067, doi. 10.1002/hon.3040
By:
- Tan, Yanhong;
- Zhang, Lingli;
- Zhu, Guiyang;
- Yang, Yuchao;
- Guo, Wenzheng;
- Chen, Lanhui;
- Chang, Jianmei;
- Xu, Yang;
- Muyey, Daniel Muteb;
- Wang, Hongwei
Publication type:
Article
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 1105, doi. 10.1002/hon.3039
By:
- Condoluci, Adalgisa;
- Milan, Lisa;
- Forestieri, Gabriela;
- Terzi di Bergamo, Lodovico;
- Spina, Valeria;
- Bruscaggin, Alessio;
- Deambrogi, Clara;
- Moia, Riccardo;
- Deodato, Marina;
- Fahrni, Gaby;
- Mattarucchi, Roberta;
- Merli, Michele;
- Gerber, Bernhard;
- Stussi, Georg;
- Passamonti, Francesco;
- Gregor, Michael;
- Tedeschi, Alessandra;
- Gaidano, Gianluca;
- Rossi, Davide;
- Ceriani, Luca
Publication type:
Article
Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 1020, doi. 10.1002/hon.3038
By:
- Facon, Thierry;
- Moreau, Philippe;
- Martin, Thomas G.;
- Spicka, Ivan;
- Oriol, Albert;
- Koh, Youngil;
- Lim, Andrew;
- Mikala, Gabor;
- Rosiñol, Laura;
- Yağci, Münci;
- Cavo, Michele;
- Yong, Kwee;
- Risse, Marie‐Laure;
- Asset, Gaëlle;
- Schwab, Sandrine;
- Martinez, Gracia
Publication type:
Article
Overcoming resistance to anti‐CD19 CAR T‐cell therapy in B‐cell malignancies.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 821, doi. 10.1002/hon.3036
By:
- Yang, Xingcheng;
- Wei, Jia;
- Zhou, Jianfeng
Publication type:
Article
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 1009, doi. 10.1002/hon.3035
By:
- Martino, Enrica Antonia;
- Conticello, Concetta;
- Zamagni, Elena;
- Pavone, Vincenzo;
- Palmieri, Salvatore;
- Musso, Maurizio;
- Tacchetti, Paola;
- Mele, Anna;
- Catalano, Lucio;
- Vigna, Ernesto;
- Bruzzese, Antonella;
- Mendicino, Francesco;
- Botta, Cirino;
- Vincelli, Iolanda Donatella;
- Farina, Giuliana;
- Barone, Marialucia;
- Cangialosi, Clotilde;
- Mancuso, Katia;
- Rizziello, Ilaria;
- Rocchi, Serena
Publication type:
Article
Reimagining diversity in multiple myeloma clinical trials.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 689, doi. 10.1002/hon.2997
By:
- Habr, Dany;
- Corsaro, Massimo
Publication type:
Article
Ibrutinib dose intensity in high‐risk chronic lymphocytic leukemia.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 1100, doi. 10.1002/hon.3032
By:
- Forestieri, Gabriela;
- Terzi di Bergamo, Lodovico;
- Deodato, Marina;
- Frustaci, Anna Maria;
- Moia, Riccardo;
- Deambrogi, Clara;
- Rasi, Silvia;
- Autore, Francesco;
- Merli, Michele;
- Mattarucchi, Roberta;
- Fahrni, Gaby;
- Scarfo', Lydia;
- Gussetti, Daniela;
- Bulian, Pietro;
- Zanatta, Annagiulia;
- Spina, Valeria;
- Bruscaggin, Alessio;
- Pini, Katia;
- Piffaretti, Deborah;
- Pirosa, Maria Cristina
Publication type:
Article
A novel start‐loss mutation of the SH2B3 gene in a family with myeloproliferative neoplasms.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 1109, doi. 10.1002/hon.3023
By:
- Beghini, Alessandro;
- Leuzzi, Livia;
- Abazari, Nazanin;
- Bossi, Luca E.;
- Guido, Valentina;
- Trojani, Alessandra;
- Cairoli, Roberto
Publication type:
Article
Effectiveness of a third dose of BNT162b2 anti‐SARS‐CoV‐2 mRNA vaccine over a 6‐month follow‐up period in allogenic hematopoietic stem cells recipients.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 1097, doi. 10.1002/hon.3006
By:
- Chevallier, Patrice;
- Jullien, Maxime;
- Peterlin, Pierre;
- Garnier, Alice;
- Le Bourgeois, Amandine;
- Coste‐Burel, Marianne;
- Béné, Marie C.;
- Guillaume, Thierry
Publication type:
Article
Comparing apples and oranges: The ZUMA‐7, TRANSFORM and BELINDA trials.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 1090, doi. 10.1002/hon.3001
By:
- Bommier, Côme;
- Lambert, Jérôme;
- Thieblemont, Catherine
Publication type:
Article
Finding a consensus on time‐to‐event endpoints definitions in marginal zone lymphoma: A Delphi method.
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 1086, doi. 10.1002/hon.2988
By:
- Bommier, Côme;
- Lambert, Jérôme;
- Nowakowski, Grzegorz;
- Zucca, Emanuele;
- Thieblemont, Catherine
Publication type:
Article
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 704, doi. 10.1002/hon.3031
By:
- Bruzzese, Antonella;
- Derudas, Daniele;
- Galli, Monica;
- Martino, Enrica Antonia;
- Rocco, Stefano;
- Conticello, Concetta;
- Califano, Catello;
- Giuliani, Nicola;
- Mangiacavalli, Silvia;
- Farina, Giuliana;
- Lombardo, Alessandra;
- Brunori, Marino;
- Rossi, Elena;
- Antonioli, Elisabetta;
- Ria, Roberto;
- Zambello, Renato;
- Di Renzo, Nicola;
- Mele, Giuseppe;
- Marcacci, Gianpaolo;
- Pietrantuono, Giuseppe
Publication type:
Article
Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B‐cell lymphoma and treated with anthracyclines.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 626, doi. 10.1002/hon.3034
By:
- Diamond, Akiva;
- Ayyappan, Sabarish;
- Cao, Shufen;
- Tashtish, Nour;
- Boughan, Kirsten;
- Cooper, Brenda;
- Fu, PingFu;
- Caimi, Paolo F.
Publication type:
Article
Outcome of therapy‐related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 752, doi. 10.1002/hon.2991
By:
- Itonaga, Hidehiro;
- Kida, Michiko;
- Hamamura, Atsushi;
- Uchida, Naoyuki;
- Ozawa, Yukiyasu;
- Fukuda, Takahiro;
- Ueda, Yasunori;
- Kataoka, Keisuke;
- Katayama, Yuta;
- Ota, Shuichi;
- Matsuoka, Ken‐ichi;
- Kondo, Tadakazu;
- Eto, Tetsuya;
- Kanda, Junya;
- Ichinohe, Tatsuo;
- Atsuta, Yoshiko;
- Miyazaki, Yasushi;
- Ishiyama, Ken
Publication type:
Article
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 734, doi. 10.1002/hon.3029
By:
- Sartor, Chiara;
- Arpinati, Mario;
- Chirumbolo, Gabriella;
- Dozza, Luca;
- Cristiano, Gianluca;
- Nanni, Jacopo;
- Marconi, Giovanni;
- Robustelli, Valentina;
- Vigliotta, Ilaria;
- Parisi, Sarah;
- Terragna, Carolina;
- Testoni, Nicoletta;
- Paolini, Stefania;
- Martinelli, Giovanni;
- Curti, Antonio;
- Cavo, Michele;
- Papayannidis, Cristina
Publication type:
Article
Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4‐MYC oncogenic axis in multiple myeloma.
Published in:
Hematological Oncology, 2022, v. 40, n. 3, p. 417, doi. 10.1002/hon.3016
By:
- Agnarelli, Alessandro;
- Mitchell, Simon;
- Caalim, Gillian;
- Wood, C. David;
- Milton‐Harris, Leanne;
- Chevassut, Timothy;
- West, Michelle J.;
- Mancini, Erika J.
Publication type:
Article
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 609, doi. 10.1002/hon.3028
By:
- Rigacci, Luigi;
- Battistini, Roberta;
- Kovalchuk, Sofia;
- Zoli, Valerio;
- Puccini, Benedetta;
- Evangelista, Andrea;
- Arcaini, Luca;
- Flenghi, Leonardo;
- Visco, Carlo;
- Mian, Michael;
- Di Rocco, Alice;
- Peracchio, Claudia;
- Gotti, Manuel;
- Tisi, Maria Chiara;
- Palombi, Francesca;
- Pozzi, Samantha;
- Gioia, Daniela;
- Viero, Piera;
- Martelli, Maurizio
Publication type:
Article
Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 588, doi. 10.1002/hon.3027
By:
- Piñeyroa, Juan A.;
- Magnano, Laura;
- Rivero, Andrea;
- Rivas‐Delgado, Alfredo;
- Nadeu, Ferran;
- Correa, Juan Gonzalo;
- Giné, Eva;
- Villamor, Neus;
- Filella, Xavier;
- Colomer, Dolors;
- López, Mònica;
- López‐Oreja, Irene;
- Costa, Dolors;
- Aymerich, Marta;
- Beà, Sílvia;
- López‐Guillermo, Armando;
- Campo, Elías;
- Delgado, Julio;
- Mozas, Pablo
Publication type:
Article
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot study.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 787, doi. 10.1002/hon.3026
By:
- Qu, Shiqiang;
- Xu, Zefeng;
- Qin, Tiejun;
- Li, Bing;
- Pan, Lijuan;
- Chen, Jia;
- Yan, Xin;
- Wu, Junying;
- Zhang, Yudi;
- Zhang, Peihong;
- Gale, Robert Peter;
- Xiao, Zhijian
Publication type:
Article
Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine‐treated, interimPET‐negative classical Hodgkin Lymphoma patients: A radio‐genomic study.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 645, doi. 10.1002/hon.3025
By:
- Durmo, Rexhep;
- Donati, Benedetta;
- Rebaud, Louis;
- Cottereau, Anne Segolene;
- Ruffini, Alessia;
- Nizzoli, Maria Elena;
- Ciavarella, Sabino;
- Vegliante, Maria Carmela;
- Nioche, Christophe;
- Meignan, Michel;
- Merli, Francesco;
- Versari, Annibale;
- Ciarrocchi, Alessia;
- Buvat, Irene;
- Luminari, Stefano
Publication type:
Article
Outcome of older myeloma patients in relationship to comorbidities and availability of second‐generation novel agents in a real‐life setting.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 716, doi. 10.1002/hon.3024
By:
- Lalive d'Epinay, Murielle;
- Güsewell, Sabine;
- Graf, Nicole;
- Mey, Ulrich J. M.;
- Driessen, Christoph;
- Hitz, Felicitas
Publication type:
Article
Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non‐inferiority, randomized controlled trial.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 777, doi. 10.1002/hon.3017
By:
- Wen, Bingbing;
- Zhang, Xiaohan;
- Chen, Shiyu;
- Fan, Jingchao;
- Yang, Sitian;
- Cai, Yun;
- Wang, Pengcheng;
- Zhang, Qiaoxia;
- Gu, Qingli;
- Du, Xin
Publication type:
Article
Combination of KIT and FLT3‐ITD mutation status with minimal residual disease levels guides treatment strategy for adult patients with inv(16) acute myeloid leukemia in first complete remission.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 724, doi. 10.1002/hon.3015
By:
- Wang, Jun;
- Dao, Feng‐Ting;
- Wang, Yu;
- Jiang, Hao;
- Xu, Lan‐Ping;
- Zhao, Xiao‐Su;
- Zhang, Xiao‐Hui;
- Liu, Kai‐Yan;
- Huang, Xiao‐Jun;
- Jiang, Qian;
- Qin, Ya‐Zhen
Publication type:
Article